$2.33T
Total marketcap
$78.51B
Total volume
BTC 50.01%     ETH 15.35%
Dominance

AVAX AVXT Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
6.42M USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
2.41K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

AVAX Price Chart

AVAX AVXT Financial and Trading Overview

AVAX stock price 0.0001 USD
Previous Close 1.0E-6 USD
Open 1.0E-6 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 1.0E-6 - 1.0E-6 USD
52 Week Range 1.0E-6 - 0.0001 USD
Volume 2K USD
Avg. Volume 10.5K USD
Market Cap 64.17K USD
Beta (5Y Monthly) -39.013733
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (2.16%)
Ex-Dividend Date N/A
1y Target Est N/A

AVXT Valuation Measures

Enterprise Value 3.1M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.4503298
Price/Book (mrq) N/A
Enterprise Value/Revenue 21.767
Enterprise Value/EBITDA -0.528

Trading Information

AVAX Stock Price History

Beta (5Y Monthly) -39.013733
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.0001 USD
52 Week Low 1.0E-6 USD
50-Day Moving Average 0.0001 USD
200-Day Moving Average 0.0001 USD

AVXT Share Statistics

Avg. Volume (3 month) 10.5K USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 0
Float N/A
Short Ratio 0
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short 0
Short % of Float N/A
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2010
Most Recent Quarter (mrq) December 31, 2010
Next Fiscal Year End December 31, 2011

Profitability

Profit Margin 0%
Operating Margin (ttm) -4151.67%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -457.31%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 142.5K USD
Revenue Per Share (ttm) 0.001 USD
Quarterly Revenue Growth (yoy) 374.90%
Gross Profit (ttm) 142.5K USD
EBITDA -5873681 USD
Net Income Avi to Common (ttm) -11993094 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 86.4K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 3.19M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.019
Book Value Per Share (mrq) -0.038

Cash Flow Statement

Operating Cash Flow (ttm) -3439805 USD
Levered Free Cash Flow (ttm) -2413159 USD

Profile of AVAX

Country United States
State PA
City Philadelphia
Address 2000 Hamilton Street
ZIP 19130
Phone 215-241-9760
Website https://www.avax-tech.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 9

AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.

Q&A For AVAX Stock

What is a current AVXT stock price?

AVAX AVXT stock price today per share is 0.0001 USD.

How to purchase AVAX stock?

You can buy AVXT shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for AVAX?

The stock symbol or ticker of AVAX is AVXT.

Which industry does the AVAX company belong to?

The AVAX industry is Biotechnology.

How many shares does AVAX have in circulation?

The max supply of AVAX shares is 64.17B.

What is AVAX Price to Earnings Ratio (PE Ratio)?

AVAX PE Ratio is now.

What was AVAX earnings per share over the trailing 12 months (TTM)?

AVAX EPS is 0 USD over the trailing 12 months.

Which sector does the AVAX company belong to?

The AVAX sector is Healthcare.